Vol 17, No 3 (2020)
Case report
Published online: 2020-08-30
The therapeutic use of mianserin
Psychiatria 2020;17(3):162-165.
Abstract
The article presents data on the therapeutic uses of mianserin. Mianserin has been used successfully for many years to
treat depression, but it seems that its potential could be better exploited. A case report was also provided regarding
a patient with psychogenic pain and depression who was successfully treated with mianserin.
Keywords: mianserindepressionpharmacotherapy
References
- Coppen A, Ghose K, Rao R, et al. Mianserin and lithium in the prophylaxis of depression. Br J Psychiatry. 1978; 133: 206–210.
- Kotowki W, Pużyńki S. Pychofarmakologia kliniczna i doświadczalna. PZWL, Warszawa 1996.
- Beaumont G, Gringras M, Ankier SI. Trazodone and mianserin in general practice. Psychopathology. 1984; 17 Suppl 2: 24–29.
- Bucknall C, Brooks D, Curry PV, et al. Mianserin and trazodone for cardiac patients with depression. Eur J Clin Pharmacol. 1988; 33(6): 565–569.
- Khan MC, Bennie EH, Stulemeijer SM, et al. Mianserin and doxepin in the treatment of outpatient depression with anxiety. Br J Clin Pharmacol. 1983; 15 Suppl 2: 213S–218S.
- Davies P, Ijaz S, Williams CJ, et al. Pharmacological interventions for treatment-resistant depression in adults. Cochrane Database Syst Rev. 2019; 12: CD010557.
- Papakostas GI. Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. J Clin Psychiatry. 2009; 70 Suppl 6: 16–25.
- Moliere F, Bubrovszky M, Haesebaert F, et al. Depression resistante: les startegies de changement et d’association de medicaments antidepresseurs. Press Med. 2016; 45(3): 329–337.
- Maes M, Libbrecht I, van Hunsel F, et al. Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance. J Clin Psychopharmacol. 1999; 19(2): 177–182.
- Święcicki Ł, Pużyński S. Skojarzone leczenie depresji lekami przeciwdepresyjnymi i pindololem – otwarte badanie skuteczności 14 dniowej terapii. Farmakoterapia Psych Neurol. 2001; 3: 285–290.
- Zarse K, Ristow M. Antidepressants of the serotonin-antagonist type increase body fat and decrease lifespan of adult Caenorhabditis elegans. PLoS One. 2008; 3(12): e4062.
